Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ensysce Biosciences, Inc.

NASDAQ: ENSC · Life Sciences · 5 alerts · CIK 1716947

Share price
$0.4095Close, Nov 16
Market cap
$7.97M
Shares outstanding
19.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ensysce Biosciences, Inc. filings on SEC EDGAR ↗

6:04 AM ET 8-K/A
M&A Deal

Ensysce Biosciences M&A Deal with Cy Biopharma, Inc.

Ensysce Biosciences completed the acquisition of Cy Biopharma, Inc. on August 5, 2026, through a two-step merger process. As consideration, Ensysce issued 282,122 shares of Series C Preferred Stock to Cy Biopharma equityholders, with each share convertible into 1,000 shares of common stock. This filing (Amendment No. 2) provides required historical and pro forma financial statements related to the transaction.

Counterparty
Cy Biopharma, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.